FDA approves Rituxan biosimilar
(By Alia Paavola for Becker’s Hospital Review) The FDA has approved Pfizer’s biosimilar to Rituxan, a treatment for some cancers and autoimmune
Read More(By Alia Paavola for Becker’s Hospital Review) The FDA has approved Pfizer’s biosimilar to Rituxan, a treatment for some cancers and autoimmune
Read More(By Emmarie Huetteman for Kaiser Health News) When Washington returned from its winter holiday break in January, it seemed everyone
Read More(By Alia Paavola for Becker’s Hospital Review) The FDA has approved several new generics of Lyrica, a brand-name drug manufactured by Pfizer
Read More(By Dinesh Thakur for STAT) Katherine Eban’s new book, “Bottle of Lies,” has focused a very intense spotlight on the mostly ignored
Read More(By Shefali Luthra for Kaiser Health News) As part of its effort to curb high prescription drug costs, the Trump
Read More(By Judith Graham for Kaiser Health News) By all accounts the woman, in her late 60s, appeared to have severe
Read More(By Alia Paavola for Becker’s Hospital Review) FDA inspectors claim that Strides Pharma Science, an India-based drugmaker that sells numerous
Read MoreAre Medicare Supplements and Medicare Advantage PPO Plans the same? No, they are two completely different types of Medicare policies.
Read More(By JoNel Aleccia for Kaiser Health News) On Wednesday, Alexis Conell will mark seven years since she received the kidney
Read MoreSome veterans choose not to enroll in Medicare Part B because they’re going to use the VA healthcare system for
Read More